Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

GRTS

Gritstone Bio Inc

Dec 01 • 04:00PM ET

1.53

Dollar change +0.23
Percentage change 17.69	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.30	Insider Own	8.17%	Shs Outstand	95.34M	Perf Week	11.68%
Market Cap	145.87M	Forward P/E	-	EPS next Y	-1.19	Insider Trans	0.00%	Shs Float	87.55M	Perf Month	-15.47%
Income	-138.96M	PEG	-	EPS next Q	-0.29	Inst Own	45.91%	Short Float / Ratio	9.62% / 3.55	Perf Quarter	-16.39%
Sales	2.63M	P/S	55.46	EPS this Y	4.67%	Inst Trans	-4.95%	Short Interest	8.42M	Perf Half Y	-25.73%
Book/sh	0.79	P/B	1.92	EPS next Y	5.57%	ROA	-70.82%	Target Price	10.40	Perf Year	-47.96%
Cash/sh	0.89	P/C	1.71	EPS next 5Y	-	ROE	-131.82%	52W Range	1.14 - 4.05	Perf YTD	-55.65%
Dividend	-	P/FCF	-	EPS past 5Y	1.04%	ROI	-85.11%	52W High	-62.22%	Beta	0.43
Dividend %	-	Quick Ratio	3.88	Sales past 5Y	247.46%	Gross Margin	-525.70%	52W Low	34.29%	ATR	0.14
Employees	233	Current Ratio	3.88	Sales Q/Q	-17.20%	Oper. Margin	-5652.55%	RSI (14)	49.44	Volatility	10.00% 8.89%
Optionable	Yes	Debt/Eq	1.29	EPS Q/Q	3.70%	Profit Margin	-5283.73%	Rel Volume	0.80	Prev Close	1.30
Shortable	Yes	LT Debt/Eq	1.21	Earnings	Nov 08 AMC	Payout	-	Avg Volume	2.37M	Price	1.53
Recom	1.00	SMA20	3.59%	SMA50	-14.16%	SMA200	-26.55%	Volume	1,886,420	Change	17.69%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-31-23	Initiated	Evercore ISI	Outperform
Mar-28-23	Initiated	B. Riley Securities	Buy	$8
Oct-31-22	Initiated	Piper Sandler	Overweight	$6
Aug-22-22	Downgrade	Goldman	Neutral → Sell	$2
Dec-15-21	Resumed	Goldman	Neutral	$15
Oct-15-21	Resumed	BTIG Research	Buy	$20
Jan-20-21	Downgrade	Robert W. Baird	Outperform → Underperform	$8
Jul-26-19	Initiated	Robert W. Baird	Outperform	$17
Mar-15-19	Initiated	Raymond James	Outperform
Mar-07-19	Initiated	H.C. Wainwright	Buy	$17
Oct-23-18	Initiated	Goldman	Neutral	$18
Oct-23-18	Initiated	BTIG Research	Buy	$26

Show Previous Ratings

Nov-20-23 07:00AM	Gritstone bio to Participate in Upcoming Investor Conferences (GlobeNewswire)
Nov-08-23 06:43PM	Gritstone Bio Inc (GRTS) Reports Q3 2023 Financial Results and Progress in Vaccine Development (GuruFocus.com) -7.65%
04:05PM	Gritstone bio Reports Third Quarter 2023 Financial Results and Provides Corporate Updates (GlobeNewswire)
Nov-07-23 04:30PM	Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Oct-12-23 05:00PM	Genevant Sciences LNP Technology Used in samRNA Covid-19 Vaccine Candidate Behind Gritstone bio's BARDA Award (GlobeNewswire)
07:10AM	Loading…
Oct-11-23 07:10AM	Presentations at IDWeek 2023 Highlight Potentially Differentiated Immunogenicity of Gritstone bio's Next Generation COVID-19 Vaccine (GlobeNewswire) -10.53%
Oct-10-23 07:00AM	Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Oct-04-23 04:05PM	Gritstone bio Announces Presentations from Phase 1 Studies Evaluating Next-Generation Vaccine Candidate for COVID-19 at IDWeek 2023 (GlobeNewswire) +20.69%
Sep-27-23 04:01PM	Gritstone bio Awarded BARDA Contract to Conduct Comparative Phase 2b Study Evaluating Next-Generation Vaccine Candidate for COVID-19 Valued at up to $433 Million (GlobeNewswire)
Sep-13-23 04:30PM	Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -5.14%
Sep-05-23 07:00AM	Gritstone bio to Participate in Upcoming Investor Conferences (GlobeNewswire) -6.01%
Aug-16-23 04:30PM	Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Aug-15-23 07:00AM	Gritstone bio and Genevant Sciences Announce Option and License Agreement (GlobeNewswire)
Aug-09-23 04:05PM	Gritstone bio Reports Second Quarter 2023 Financial Results and Provides Corporate Updates (GlobeNewswire)
Aug-07-23 07:00AM	Gritstone bio Partners with Friends of Cancer Research (Friends) on the ctDNA to Monitor Treatment Response (ctMoniTR) Project (GlobeNewswire) -5.03%
07:00AM	Loading…
Jul-17-23 07:00AM	Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +5.66%
Jul-04-23 06:55AM	Gritstone bio (NASDAQ:GRTS) shareholders have endured a 70% loss from investing in the stock three years ago (Simply Wall St.)
Jun-13-23 07:00AM	Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jun-08-23 07:00AM	Gritstone bio Announces Publication of Interim Results from Phase 1 Study of Self-amplifying mRNA (samRNA) Vaccine Against COVID-19 in Nature Communications (GlobeNewswire)
Jun-01-23 04:30PM	Gritstone bio to Participate in Upcoming Investor Conferences (GlobeNewswire)
May-24-23 05:00PM	Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
May-16-23 06:05AM	The Consensus EPS Estimates For Gritstone bio, Inc. (NASDAQ:GRTS) Just Fell Dramatically (Simply Wall St.) -5.08%
May-11-23 04:05PM	Gritstone bio Reports First Quarter 2023 Financial Results and Provides Corporate Updates (GlobeNewswire)
May-03-23 07:00AM	Gritstone bio to Report First Quarter 2023 Financial Results and Provide Corporate Update on May 11, 2023 (GlobeNewswire)
Apr-21-23 06:05AM	Both individual investors who control a good portion of Gritstone bio, Inc. (NASDAQ:GRTS) along with institutions must be dismayed after last week's 14% decrease (Simply Wall St.)
Apr-17-23 07:01AM	Gritstone bio Presents 6-month Neutralizing Antibody (nAb) Data at ECCMID 2023 from Two Phase 1 Studies Evaluating Self-amplifying mRNA (samRNA) Against SARS-CoV-2 (CORAL) (GlobeNewswire) -5.94%
07:00AM	Gritstone bio Presents Advances in Neoantigen Prediction and Cancer Vaccine Immunogenicity at the 2023 AACR Annual Meeting (GlobeNewswire)
Apr-10-23 07:00AM	Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Apr-04-23 06:30PM	Gritstone bio Announces Presentations Evaluating Self-amplifying mRNA (samRNA) Against SARS-CoV-2 at ECCMID 2023 (GlobeNewswire) -8.33%
Mar-15-23 07:00AM	Gritstone bio Announces Presentations on Neoantigen Prediction Capabilities and Cancer Vaccine Programs at the 2023 AACR Annual Meeting (GlobeNewswire)
07:18AM	Loading…
Mar-11-23 07:18AM	Gritstone bio Full Year 2022 Earnings: Beats Expectations (Simply Wall St.)
Mar-09-23 04:05PM	Gritstone bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Updates (GlobeNewswire)
Mar-02-23 07:00AM	Gritstone bio to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update on March 9, 2023 (GlobeNewswire)
Feb-27-23 04:06PM	Gritstone bio to Participate in 43rd Annual Cowen Healthcare Conference (GlobeNewswire)
04:05PM	Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Feb-14-23 07:00AM	Gritstone bio and the National Cancer Institute (NCI) Establish a Clinical Trial Agreement to Evaluate a Neoantigen Cell Therapy-Vaccine Combination (GlobeNewswire)
Jan-25-23 05:34AM	Investors in Gritstone bio (NASDAQ:GRTS) have unfortunately lost 66% over the last three years (Simply Wall St.)
Jan-24-23 07:00AM	Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jan-18-23 05:30PM	Gritstone bio to Participate in Upcoming Investor Conferences (GlobeNewswire) -7.58%
Dec-15-22 04:31PM	Gritstone bio to Present at 41st Annual J.P. Morgan Healthcare Conference (GlobeNewswire) -8.67%
04:30PM	Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Dec-13-22 07:00AM	Gritstone bio Granted Two New U.S. Patents for Self-amplifying mRNA (samRNA) (GlobeNewswire) +20.54%
Dec-05-22 08:30AM	Predictive Oncology Appoints Leading Biopharma Executive Matthew J. Hawryluk Ph.D. to the Board of Directors (GlobeNewswire)
Nov-21-22 07:30AM	Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Nov-17-22 07:00AM	Gritstone to Participate in Upcoming Investor Conferences (GlobeNewswire)
Nov-10-22 09:00AM	Gritstone Announces Updated Overall Survival Results from GRANITE Phase 1/2 Study and Poster at SITC 2022 (GlobeNewswire) +15.74%
Nov-03-22 06:04PM	How biotech companies are building drug pipelines with PIPEs (American City Business Journals) +7.67%
04:05PM	Gritstone Reports Third Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire)
Oct-25-22 07:01AM	Gritstone bio Announces Private Placement of $45.0 Million (GlobeNewswire) +8.41%
07:00AM	Gritstone Presents Positive Results from Two Phase 1 CORAL Studies, Providing Further Proof-of-Concept for Self-amplifying mRNA (samRNA) in Infectious Diseases (GlobeNewswire)
Oct-19-22 09:43AM	Gritstone bio, Inc.'s (NASDAQ:GRTS) largest shareholders are individual investors with 48% ownership, institutions own 32% (Simply Wall St.)
07:00AM	Gritstone to Host Data Update on CORAL and Discuss the Application of Self-amplifying mRNA (samRNA) in Infectious Diseases (GlobeNewswire)
Oct-17-22 07:00AM	Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Sep-20-22 07:00AM	Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Sep-12-22 07:00AM	Gritstone Presents Positive Initial Phase 2 Data in Late-Line Solid Tumor Patients Treated With KRAS-Directed Immunotherapy (SLATE) at ESMO 2022 (GlobeNewswire) +7.52%
Sep-01-22 04:05PM	Gritstone to Participate in Two Upcoming Investor Conferences (GlobeNewswire)
Aug-17-22 07:00AM	Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -7.79%
Aug-15-22 04:05PM	Nature Medicine Publishes Interim Results from Gritstone bios Phase 1/2 Study of GRANITE, Individualized Neoantigen Vaccine for Solid Tumors (GlobeNewswire)
Aug-10-22 04:05PM	Gritstone Appoints Dr. Lawrence Larry Corey to its Board of Directors (GlobeNewswire)
Aug-04-22 04:05PM	Gritstone Reports Second Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire) +21.43%
Aug-01-22 06:38AM	Investors in Gritstone bio (NASDAQ:GRTS) have unfortunately lost 73% over the last three years (Simply Wall St.)
Jul-26-22 07:00AM	Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jul-21-22 04:06PM	Gritstone to Report Second Quarter 2022 Financial Results and Provide Corporate Update on August 4, 2022 (GlobeNewswire)
04:05PM	Gritstone Establishes Credit Facility for Up to $80 Million with Hercules Capital and Silicon Valley Bank (GlobeNewswire)
Jul-05-22 08:00AM	Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +10.98%
Jun-10-22 08:00AM	Gritstone Announces Results from Preclinical Study of its Self-amplifying mRNA (samRNA) Vaccine Against SARS-CoV-2 Published in Nature Communications (GlobeNewswire)
Jun-08-22 04:05PM	Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
08:51AM	Gritstone bio (NASDAQ:GRTS) Will Have To Spend Its Cash Wisely (Simply Wall St.)
Jun-02-22 08:00AM	Gritstone Earns 2022 Great Place to Work Certification (GlobeNewswire) +5.56%
May-31-22 08:00AM	Gritstone Announces Updated Overall Survival Results in Advanced Colorectal Cancer Patients from Phase 1/2 Study of GRANITE and Trial in Progress Poster at ASCO (GlobeNewswire) +9.19%
May-17-22 05:00PM	Gritstone to Participate in H.C. Wainwright Global Investment Conference (GlobeNewswire)
May-09-22 08:32AM	Are Institutions Heavily Invested In Gritstone bio, Inc.'s (NASDAQ:GRTS) Shares? (Simply Wall St.) -8.79%
May-06-22 07:30PM	CORRECTION -- Gritstone Reports First Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire) -7.36%
May-05-22 04:05PM	Gritstone Reports First Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire) -5.84%
May-02-22 07:00AM	Gritstone to Release First Quarter 2022 Financial Results on May 5 and Announces Q&A Opportunity for Shareholders (GlobeNewswire) +5.79%
Apr-27-22 04:05PM	Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Apr-12-22 04:35PM	Gritstone Presentations at AACR Further Support Expertise in Neoantigen Vaccine Design and Delivery (GlobeNewswire)
Mar-30-22 07:00AM	Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Mar-17-22 12:14PM	Analysts Just Made A Major Revision To Their Gritstone bio, Inc. (NASDAQ:GRTS) Revenue Forecasts (Simply Wall St.) +6.52%
Mar-10-22 04:05PM	Gritstone Reports Fourth Quarter 2021 and Full Year 2021 Financial Results and Provides Corporate Updates (GlobeNewswire)
Mar-08-22 05:15PM	Gritstone Announces Three Presentations for Tumor-Specific Neoantigen (TSNA) Oncology Programs, GRANITE and SLATE, at the 2022 AACR Annual Meeting (GlobeNewswire)
Feb-24-22 07:00AM	Gritstone to Participate in Cowen 42nd Annual Health Care Conference (GlobeNewswire) +7.34%
Feb-22-22 05:34AM	Gritstone bio (NASDAQ:GRTS) shareholders have endured a 63% loss from investing in the stock a year ago (Simply Wall St.) -5.95%
Feb-08-22 04:05PM	Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
07:00AM	Gritstone to Participate in Precision Oncology Panel at BIO CEO & Investor Conference (GlobeNewswire)
Feb-07-22 10:45AM	2 Beaten-Down Biotech Stocks That Could Make You Filthy Rich (Motley Fool)
Jan-25-22 04:05PM	Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jan-13-22 07:00AM	Gritstone Announces First Patient Enrolled for Phase 2/3 Trial Evaluating Individualized Neoantigen Vaccine GRANITE for First Line (1L) Maintenance Treatment of Metastatic, Microsatellite-Stable Colorectal Cancer (MSS-CRC) (GlobeNewswire)
Jan-12-22 06:15AM	Which Vaccine Stocks Will Make You a Fortune in 2022? (Motley Fool) -5.88%
Jan-05-22 05:14PM	Is Gritstone Stock a Buy Right Now? This Is What You Need to Know (TipRanks) -8.26%
Jan-04-22 07:00AM	Gritstone Announces Positive Clinical Results from First Cohort of a Phase 1 Study (CORAL-BOOST) Evaluating a T Cell-Enhanced Self-Amplifying mRNA (samRNA) Vaccine Against COVID-19 (GlobeNewswire) -42.41%
Dec-30-21 07:00AM	Gritstone Announces Presentations during Three Upcoming Investor Conferences (GlobeNewswire)
Dec-17-21 07:00AM	Gritstone Announces Changes to Its Board of Directors (GlobeNewswire) +13.87%
Dec-13-21 04:05PM	Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
07:00AM	Gritstone bio Added to the Nasdaq Biotechnology Index (GlobeNewswire)
Dec-09-21 08:41AM	Direxion Launches mRNA ETF (MSGR) (PR Newswire)
Dec-06-21 07:00AM	Gritstone bio and CEPI Expand Vaccine Agreement to Tackle Omicron Variant (GlobeNewswire) -7.51%
Nov-29-21 07:00AM	The Omicron Variant of SARS-CoV-2 has Minimal Impact on the T Cell Epitopes (Targets) Contained within Gritstones Self-Amplifying mRNA COVID-19 Vaccines (GlobeNewswire) -5.58%
Nov-23-21 04:05PM	Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Nov-10-21 07:00AM	Gritstone Announces Positive Preclinical Data in Non-Human Primate Challenge Study with Second-Generation COVID-19 Vaccine Against SARS-CoV-2 (GlobeNewswire)

Gritstone bio, Inc. clinical-stage biotechnology company, which engages in developing the next generation of cancer immunotherapies to fight multiple cancer types. The company was founded by Andrew Allen, Timothy Chan, Mark Cobbold, Graham Lord, Naiyer Rizvi and Jean-Charles Soria in August 2015 and is headquartered in Emeryville, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Economides Vassiliki	See Remarks	May 23	Buy	1.90	12,000	22,829	214,058	May 24 05:24 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

GRTS

Gritstone Bio Inc

Upgrade your FINVIZ experience